Euro Stoxx 50 falls 0.6% as AI-linked tech shares weigh
MOEX Russia Index falls to 2,480.37 points after Monday pullback
AEX slips 0.60% to 1,134.13 as chip stocks weigh
FTSE 100 slips 0.1% as miners weaken ahead of UK data
ATX slips 0.36% as global technology pressure weighs on Vienna
DAX ends Monday 0.57% lower at 26,598.64 as technology stocks weigh
S&P / TSX Composite falls 0.72% as energy and materials weigh
OHB's Order Book Is Real; SATCOMBw4 Is Still a Promise
Rheinmetall's €78 Billion Backlog Runs Into a Delivery Calendar That Won't Cooperate
Allianz Wins Workplace Accolade and Broker Upgrades, but Bank of America Stays on the Fence
XRP's Roadmap Improves the Plumbing While the Money Walks Out the Door
ASML Investors Face Two Very Different Kinds of Noise
Vanguard's All-World ETF Takes In €1.2 Billion in a Week Even as Chip Stocks Stumble
Gold's Double Bind: Washington's Rate Path and Shanghai's Retreating Bulls
Wienerberger's €140 Million Self-Help Target Faces Its First Real Test
AMD Slides With Chip Peers While Closing World Labs Deal and Expanding Quantum, Cloud Ties
Deutz Chief Flags Cologne Investment as Defence Arm Reshapes Earnings Outlook
Almonty's Sangdong Ramp-Up Hits a Water Treatment Snag as Two Analysts Trim Targets
ams-OSRAM's Cash Pledge Meets a Skeptical Tape
SanDisk Slides as Wall Street Rethinks the AI Spending Curve
BASF Pitches 2028 Soy Launch as Jefferies Flags a Profit Gap
Infineon's Margin Test Looms Larger Than a Single Bad Session
Renk Insiders Pick Up Shares Off-Market as Order Book Swells Past EUR 7.6 Billion
Deutsche Telekom Chosen by ECB for Digital Euro Role as AI Spending and Buybacks Run in Tandem
Ocugen Has the Plant Ready and the Cash Mapped to 2028 — Now Comes the Shareholder Vote
Xiaomi's Green Aluminium Coup Overshadowed by CLSA's Deepening Profit Cut
Nokia's ASUS Patent Truce and Nordic AI Factory Bid Fail to Lift Stock as Tech Selloff Bites
Rheinmetall's Order Book Is Full — Its Cash Register Is Not
T1 Energy Trades Near-Term Pain for Long-Term Capacity
Micron Slips as Washington Tightens Chip Rules and a DRAM Lawsuit Clears Its First Hurdle
Galimedix Therapeutics outlines development plans in Alzheimer's disease at CTAD 2026